Image

Global Medical Bionic Implant Artificial Organs Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Medical Bionic Implant Artificial Organs Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Sep 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Medical Bionic Implant Artificial Organs Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 22.31 Billion
Diagram Market Size (Forecast Year) USD 37.75 Billion
Diagram CAGR %

Major Markets Players

  • CONMED Corporation
  • Wright Medical Group
  • Stryker
  • Medtronic
  • Smith+Nephew

Global Medical Bionic Implant Artificial Organs Market, By Product (Vision Bionics, Ear Bionics, Orthopedic Bionics, Heart Bionics, Neural/Brain Bionics), Method of Fixation (Implantable, Externally Worn), Technology (Electronic, Mechanical), End User (Hospitals and Clinics, Research and Academic Institutes, Others) – Industry Trends and Forecast to 2030.

Medical Bionic Implant Artificial Organs Market

Medical Bionic Implant Artificial Organs Market Analysis and Size

It has been observed that the growing number of cases of organ failure has increased the demand for replaceable organs, which is propelling the medical bionic implant/artificial organs market to a large extent. According to the National Kidney Foundation, approximately 121,678 people in the U.S. were waiting for lifesaving organ transplants in 2016. It is also reported that 17,107 kidney transplants were performed in the U.S. in 2014. Organ failure is more common in the elderly population, which is more vulnerable to health issues such as ophthalmic diseases, gastrointestinal problems, orthopedic diseases, cancer, and others.

Data Bridge Market Research analyses that the global medical bionic implant artificial organs market, valued at USD 22.31 Billion in 2022, and is estimated to reach USD 37.75 Billion by 2030, growing at a CAGR of 7.80% during the forecast period of 2023 to 2030. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Medical Bionic Implant Artificial Organs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

By Product (Vision Bionics, Ear Bionics, Orthopedic Bionics, Heart Bionics, Neural/Brain Bionics), Method of Fixation (Implantable, Externally Worn), Technology (Electronic, Mechanical), End User (Hospitals and Clinics, Research and Academic Institutes, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

CONMED Corporation (U.S.), Wright Medical Group N.V. (U.S.), Stryker (U.S.), Medtronic (Ireland), Smith+Nephew (UK), Zimmer Biomet (U.S.), Integra LifeSciences (U.S.), B. Braun Melsungen AG (Germany), Arthrex (US), Baxter (U.S.), Medical Device Business Services, Inc. (U.S.), Globus Medical (U.S.), DJO, LLC (U.S.), NuVasive, Inc. (U.S.), ORTHOPAEDIC IMPLANT CO. (U.S.), Aesculap Inc. (U.S.), Flexicare Medical Limited (U.K.), BioTek Instruments, Inc. (U.S.), Narang Medical Limited (India), Auxein Medical (India), Uteshiya Medicare (India)

Market Opportunities

  • Rapid technological advancements and rising government assistance
  • Continuous research and development efforts to improve the design, functionality, and efficiency of bionic implants and artificial organs

Market Definition

Artificial organs and implants are prosthetics or devices designed specifically for implantation in the human body to mimic the functioning of the original organ. The most important aspect of such implants is that they function as if they were normal organs, with no interruptions. Artificial organs and bionic implants used in the medical field these devices are designed to replace or enhance the functionality of damaged or non-functioning organs in the human body. They are typically made of biocompatible materials and can be implanted permanently or temporarily, depending on the specific medical condition. The market includes a wide range of artificial organs, such as artificial hearts, cochlear implants, pacemakers, prosthetic limbs, and artificial pancreas, among others.

Global Medical Bionic Implant Artificial Organs Market Dynamics

Drivers

  • Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and organ failure, is a significant driver for the medical bionic implant artificial organs market. These conditions often require the use of artificial organs or bionic implants to restore or maintain normal bodily functions.

  • Technological Advancements

Advances in medical technology have led to the development of more sophisticated and efficient bionic implants and artificial organs. Improved materials, miniaturization, wireless connectivity, and advanced sensors have enhanced the performance and functionality of these devices, driving the market growth.

  • Growing Aging Population

The global aging population is a key driver for the medical bionic implant artificial organs market. As people age, the risk of chronic diseases and organ failure increases, leading to a higher demand for artificial organs and bionic implants. The elderly population requires medical interventions to improve their quality of life, creating opportunities for market growth.

Opportunities

  • Increasing Awareness and Acceptance

Growing awareness about the benefits of medical bionic implant artificial organs among patients, healthcare professionals, and regulatory authorities creates opportunities for market expansion. Increased acceptance of these devices as a viable treatment option further drives market growth.

  • Emerging Markets

Developing economies, particularly in Asia-Pacific and Latin America, present significant growth opportunities for the medical bionic implant artificial organs market. Rising healthcare infrastructure, improving economic conditions, and increasing healthcare expenditure in these regions contribute to the market's expansion.

Restraints/Challenges

  • High Cost of Implants

The high cost associated with medical bionic implant artificial organs is a significant restraint for market growth. The expenses related to device procurement, surgical procedures, post-implantation care, and maintenance can be prohibitive for many patients and healthcare systems, limiting the market's potential.

  • Regulatory and Ethical Considerations

The medical bionic implant artificial organs market faces regulatory challenges related to the approval and commercialization of these devices. Stricter regulations and ethical concerns regarding the use of artificial organs pose challenges for manufacturers, potentially delaying product launches and hindering market growth.

This global medical bionic implant artificial organs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global medical bionic implant artificial organs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 10 March 2022, Zimmer Biomet Holdings, Inc. released WalkAI, an evolving AI design that recognizes patients1 who are expected to have a lesser gait speed outcome ninety days after hip or knee surgical intervention. WalkAI augments ZBEdge, a suite of integrated smart, robotic technologies digitally designed to offer transformative data-powered clinical insights to boost patient outcomes, with strong predictive analytic capabilities
  • In February 2022, Warburg Pincus invested USD 210 in Micro Life Sciences Pvt Ltd (parent organization of Meril group of companies). This investment will promote domestic medical devices at a high level of legitimacy in the global context, allowing them to expand their overseas footprint, attract international talent, and scale-up clinical research programs

Global Medical Bionic Implant Artificial Organs Market Scope

The medical bionic implant artificial organs market is segmented on the basis of product, method of fixation, technology and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product                                                                            

  • Vision Bionics
  • Ear Bionics
  • Orthopaedic Bionics
  • Heart Bionics
  • Neural/Brain Bionics

Method of Fixation

  • Implantable
  • Externally Worn

Technology

  • Electronic
  • Mechanical

End User

  • Hospital and clinics
  • Research and Academic Institutes
  • Others

Medical Bionic Global Medical Bionic Implant Artificial Organs Market Regional Analysis/Insights

The global medical bionic implant artificial organs market is analysed and market size insights and trends are provided by country, product, method of fixation, technology and end user as referenced above.

The countries covered in the global medical bionic implant artificial organs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the global medical bionic implant artificial organs market due to the introduction of advanced medical bionic implants by major market players in the region. 

Asia-Pacific is expected to grow at a significant rate from 2023 to 2030 in the global medical bionic implant artificial organs market because of the large patient pool, growing demand for advanced treatments, and rapid development in healthcare technology in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global medical bionic implant artificial organs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global medical bionic implant artificial organs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global medical bionic implant artificial organs market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Medical Bionic Implant Artificial Organs Market Share Analysis

The global medical bionic implant artificial organs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global medical bionic implant artificial organs market.

Some of the major players operating in the global medical bionic implant artificial organs market are:

  • CONMED Corporation (U.S.)
  • Wright Medical Group N.V. (U.S.)
  • Stryker (U.S.)
  • Medtronic (Ireland)
  • Smith+Nephew (U.K.)
  • Zimmer Biomet (U.S.)
  • Integra LifeSciences (U.S.)
  • B. Braun Melsungen AG (Germany)
  • Arthrex (U.S.)
  • Baxter (U.S.)
  • Medical Device Business Services, Inc. (U.S.)
  • Globus Medical (U.S.)
  • DJO, LLC (U.S.)
  • NuVasive, Inc. (U.S.)
  • ORTHOPAEDIC IMPLANT CO. (U.S.)
  • Aesculap Inc. (U.S.)
  • Flexicare Medical Limited (U.K.)
  • BioTek Instruments, Inc. (U.S.)
  • Narang Medical Limited (India)
  • Auxein Medical (India)
  • Uteshiya Medicare (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Medical Bionic Implant Artificial Organs Market will be worth USD 37.75 billion by 2030.
Medical Bionic Implant Artificial Organs Market growth rate is 7.80% during the forecast period.
Growing Aging Population, Technological Advancements and Increasing Prevalence of Chronic Diseases are the growth drivers of the Medical Bionic Implant Artificial Organs Market.
Product, method of fixation, technology and end-user are the factors on which the Medical Bionic Implant Artificial Organs Market research is based.
Warburg Pincus invested USD 210 in Micro Life Sciences Pvt Ltd (parent organization of Meril group of companies) and Zimmer Biomet Holdings, Inc. released WalkAI, an evolving AI design that recognizes patients1 who are expected to have a lesser gait speed outcome ninety days after hip or knee surgical intervention are the latest developments in the Medical Bionic Implant Artificial Organs Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials